Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	46.18	87.42	59.80
Graham Fair Price	-29.21	31.60	44.64
PEG	327.88	-0.53	0.12
Price/Book	12.74	7.49	6.64
Price/Cash Flow	22.68	45.72	37.27
Prices/Earnings	138.43	27.12	11.37
Price/Sales	39.88	12.04	8.61
Price/FCF	22.68	45.72	37.27
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-7.38	0.55	0.59
Operating Margin	-48.41	0.10	0.19
ROA	-51.87	0.01	0.02
ROE	0.15	0.07	-52.71
ROIC	0.04	0.02	-31.38
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	0.02	103.33
Dividends QOQ	< 0.005	< 0.005	12.37
EBIT QOQ	0.92	-0.57	-37.73
EPS QOQ	0.92	-0.51	-44.28
FCF QOQ	0.45	-0.05	-88.53
Revenue QOQ	0.18	-0.17	-5.72
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	14.69	16.65	13.38
Days Sales Outstanding (DSO)	78.02	76.68	-1.72
Inventory Turnover	6.13	5.40	-11.80
Debt/Capitalization	0.72	0.72	0.68
Quick Ratio	0.84	0.98	16.65
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	24.63	25.36	2.95
Cash	14.72	21.02	42.81
Capex	-0.49	-0.39	19.64
Free Cash Flow	4.39	4.15	-5.39
Revenue	19.00	15.77	-17.02
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.94	1.10	17.55
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	14.26	18.92	32.70
Naive Interpretation	Member

06 - Financial Health · Bad

Rating